Trial intelligence / Profile preview

CONCERVIC: Certican Switching in HCV+ Renal Transplant

NCT01469884Phase 4Completed

Sponsor
Santa Casa de Porto Alegre
Start
Nov 2011
Primary completion
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of everolimus in hepatitis C (HCV), sponsored by Santa Casa de Porto Alegre. Started Nov 2011; status: completed.

02

Drugs

everolimus
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT01469884.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01469884.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call